HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Application of Rheosorbilactum in the therapy of traumatic shock: comparative study].

Abstract
The authors have studied influence of infusion of 800 ml RHEOSORBILACTUM, 500 ml VENOFUNDIN and 800 ml of 0,9% isotonic solution of sodium chloride with speed of 50-55 ml/mines on hemostasis, the maintenance of a liquid in the thorax, hemodynamic parameters in 60 patients with traumatic shock. It was revealed that the use of investigated volume of RHEOSORBILACTUM increases reliably (P<0,05) oxygen delivery for the account of the expressed haemodynamic effect which duration is less than during the use of VENOFUNDIN. It was revealed also that RHEOSORBILACTUM increases reliably (P<0,05) quantity of liquid in the thorax without an considerable difference with other investigated medications. There was no influence of RHEOSORBILACTUM on time of trombus formation tests--prothrombin time, the international normalized index, activated partial thromboplastin time.
AuthorsF S Hlumcher, V I Chernyshov
JournalLikars'ka sprava / Ministerstvo okhorony zdorov'ia Ukraïny (Lik Sprava) 2009 Jan-Feb Issue 1-2 Pg. 33-43 ISSN: 1019-5297 [Print] Ukraine
PMID19953989 (Publication Type: Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Electrolytes
  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Sorbitol
  • Sodium Lactate
Topics
  • APACHE
  • Adolescent
  • Adult
  • Electrolytes (administration & dosage, therapeutic use)
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Hydroxyethyl Starch Derivatives (administration & dosage, therapeutic use)
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Plasma Substitutes (administration & dosage, therapeutic use)
  • Shock, Traumatic (diagnosis, physiopathology, therapy)
  • Sodium Lactate (administration & dosage, therapeutic use)
  • Sorbitol (administration & dosage, therapeutic use)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD